1[1]Jensen H K, Jensen L G, Meinertz H, et al. Spectrum of LDL receptor gene mutations in Denmark: Implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia. Atherosclerosis, 1999,146:337-344.
2[2]Thiery J, Seidel D. Safety and effectiveness of long-term LDL-apheresis in patients at high risk. Curr Opin Lipidol, 1998,9:521-526.
3[3]Stefanutti C, Vivenzio A, Lucani G, et al. LDL-apheresis: Current status. Clin Ter ,2001,152:65-69.
4Umans-Eckenhausen MAW, Defesche JC, Sijbrands EJG, et al. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet, 2001, 357: 165- 168.
5Quivers ES, Driscoll DJ.Variability in response to a low-fat, low-cholesterol diet in children with elevated low density lipoprotein cholesterol levels. Pediatrics, 1992, 89: 925.
6Heath KE, Gahan M, Whittall RA, et al. Low - density lipoprotein receptor(LDLR)gene world wide website in familial hypercholesterolemia: update, new features and mutation anlysis. Arterosclerosis, 2001, 154: 243 - 246.
7Rose V, Wilson G, Steiner G.Familial hypercholesterolemia: report of coronary death at age 3 in a ho mozygous child and prenatal diagnosis in a heterozygous sibling . J Pediatr, 1982, 100: 757- 759.
8Brorholt-Petersen JU, Jensen HK, Raungaard B, et al. LDL-receptor gene mutations and the hypocholesterolemic response to statin therapy. Chin Genet, 2001, 59: 397 - 405.
